A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: delivery service (206), carter (10), mover (2)

ImatinibChronic

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Regimen IMATINIB (chronic phase) • CML – Imatinib (chronic phase) Indication • As the preferred first-line treatment for
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/ImatinibChronic.pdf

ImatinibAccelerated

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Regimen IMATINIB (accelerated phase) • CML - Imatinib (accelerated phase) Indication • As the preferred option for the treatment
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/ImatinibAccelerated.pdf

DasatinibChronic

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia DASATINIB (chronic phase) Funding may be required for specific indications Regimen • CML – Dasatinib (chronic phase) Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/DasatinibChronic.pdf

DasatinibAccelerated

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia DASATINIB (accelerated phase) Funding may be required for specific indications Regimen • CML – Dasatinib (accelerated phase) Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/DasatinibAccelerated.pdf

Bosutinib

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Bosutinib Regimen • Bosutinib Indication • As an option for the treatment of patients with chronic phase, accelerated
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/Bosutinib.pdf

Risk-reducing bilateral salpingo-oophorectomy (RRBSO) - patient information

Description
This factsheet explains what a risk-reducing bilateral salpingo-oophorectomy (RRBSO) is, what the procedure involves, and what the potential advantages
Url
/Media/UHS-website-2019/Patientinformation/Womenshealth/Risk-reducing-bilateral-salpingo-oophorectomy-RRBSO-3080-PIL.pdf

Everolimus-Exemestane

Description
Regimen Chemotherapy Protocol BREAST CANCER EVEROLIMUS and EXEMESTANE • Breast Cancer – Everolimus-Exemestane Indication • The first or second line treatment of post
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Everolimus-Exemestane.pdf

UHS adult major trauma guidelines

Description
Adult Major Trauma Guidelines University Hospital Southampton NHS Foundation Trust Dr Mark Baxter Director of Major Trauma, Consultant in Older Persons
Url
/Media/SUHTExtranet/WessexTraumaNetwork/UHS-adult-major-trauma-guidelines.pdf

Preventing infection - patient information

Description
Preventing infection Information for patients 3 At University Hospital Southampton NHS Foundation T
Url
/Media/UHS-website-2019/Patientinformation/Visitinghospital/Preventinginfection-patientinformation.pdf

Olaparib Tablets

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCERS OLAPARIB (tablets) This regimen may require funding. Regimen • Ovarian Cancer – Olaparib (tablets) Indication • Olaparib in its tablet
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Olaparib-Tablets.pdf
21 to 30 of 33
Previous 1 2 3 4 Next